Berry Genomics Co Ltd (SHE:000710) — Market Cap & Net Worth
Market Cap & Net Worth: Berry Genomics Co Ltd (000710)
Berry Genomics Co Ltd (SHE:000710) has a market capitalization of $441.79 Million (CN¥3.02 Billion) as of September 19, 2026. Listed on the SHE stock exchange, this China-based company holds position #12988 globally and #3835 in its home market, demonstrating a -2.29% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Berry Genomics Co Ltd's stock price CN¥8.54 by its total outstanding shares 353521465 (353.52 Million). Also see Berry Genomics Co Ltd assets under control for a full breakdown of the balance sheet.
Berry Genomics Co Ltd Market Cap History: 2015 to 2026
Berry Genomics Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $2.11 Billion to $441.79 Million (-10.21% CAGR). Also see how efficiently does Berry Genomics Co Ltd generate cash for how efficiently the company converts equity into cash flow.
Berry Genomics Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Berry Genomics Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 000710 share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.41x
Berry Genomics Co Ltd's market cap is 0.41 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $2.11 Billion | $230.06 Million | -$13.01 Million | 9.19x | N/A |
| 2016 | $2.45 Billion | $247.38 Million | -$4.19 Million | 9.91x | N/A |
| 2017 | $2.92 Billion | $1.17 Billion | $232.75 Million | 2.49x | 12.53x |
| 2018 | $1.65 Billion | $1.44 Billion | $268.09 Million | 1.15x | 6.16x |
| 2019 | $1.89 Billion | $1.62 Billion | $390.62 Million | 1.17x | 4.85x |
| 2020 | $1.97 Billion | $1.54 Billion | $210.67 Million | 1.28x | 9.35x |
| 2021 | $1.00 Billion | $1.42 Billion | -$109.86 Million | 0.71x | N/A |
| 2022 | $590.25 Million | $1.37 Billion | -$252.25 Million | 0.43x | N/A |
| 2023 | $595.94 Million | $1.15 Billion | -$427.20 Million | 0.52x | N/A |
| 2024 | $437.13 Million | $1.08 Billion | -$192.43 Million | 0.41x | N/A |
Competitor Companies of 000710 by Market Capitalization
Companies near Berry Genomics Co Ltd in the global market cap rankings as of September 19, 2026. Review 000710 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Berry Genomics Co Ltd by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #89 globally with a market cap of $224.59 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #160 globally with a market cap of $150.10 Billion USD.
- WuXi AppTec Co Ltd (SHG:603259): Ranked #470 globally with a market cap of $58.08 Billion USD ( CN¥396.94 Billion CNY).
- Natera Inc (NASDAQ:NTRA): Ranked #577 globally with a market cap of $47.01 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #89 | Thermo Fisher Scientific Inc | NYSE:TMO | $224.59 Billion | $658.32 |
| #160 | Danaher Corporation | NYSE:DHR | $150.10 Billion | $212.50 |
| #470 | WuXi AppTec Co Ltd | SHG:603259 | $58.08 Billion | CN¥160.49 |
| #577 | Natera Inc | NASDAQ:NTRA | $47.01 Billion | $366.31 |
Berry Genomics Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Berry Genomics Co Ltd's market cap moved from $2.11 Billion to $ 441.79 Million, with a yearly change of -10.21%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥441.79 Million | -24.36% |
| 2025 | CN¥584.05 Million | +33.61% |
| 2024 | CN¥437.13 Million | -26.65% |
| 2023 | CN¥595.94 Million | +0.96% |
| 2022 | CN¥590.25 Million | -41.19% |
| 2021 | CN¥1.00 Billion | -49.03% |
| 2020 | CN¥1.97 Billion | +3.99% |
| 2019 | CN¥1.89 Billion | +14.73% |
| 2018 | CN¥1.65 Billion | -43.41% |
| 2017 | CN¥2.92 Billion | +18.90% |
| 2016 | CN¥2.45 Billion | +15.97% |
| 2015 | CN¥2.11 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Berry Genomics Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $441.79 Million USD |
| MoneyControl | $441.79 Million USD |
| MarketWatch | $441.79 Million USD |
| marketcap.company | $441.79 Million USD |
| Reuters | $441.79 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Berry Genomics Co Ltd
Berry Genomics Co.,Ltd, a genomics and life science company, develops and commercializes of genetic test technologies in clinical applications in China. The company offers non-invasive DNA prenatal testing service, genetic disease testing, tumor genetic testing, NextSeq CN500 gene sequencer, and laboratory solutions. It also provides technology services, such as human genome sequencing, transcri… Read more